Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-04-010105
Filing Date
2004-03-30
Accepted
2004-03-30 16:46:56
Documents
12
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2132097z10-k.htm 10-K 566335
3 EXHIBIT 10.19 a2132097zex-10_19.txt EX-10.19 4807
4 EXHIBIT 10.20 a2132097zex-10_20.txt EX-10.20 313593
5 EXHIBIT 10.21 a2132097zex-10_21.txt EX-10.21 2724
6 EXHIBIT 10.22 a2132097zex-10_22.txt EX-10.22 11805
7 EXHIBIT 14 a2132097zex-14.txt EX-14 20385
8 EXHIBIT 21.1 a2132097zex-21_1.txt EX-21.1 456
9 EXHIBIT 23.1 a2132097zex-23_1.txt EX-23.1 701
10 EXHIBIT 31.1 a2132097zex-31_1.txt EX-31.1 3693
11 EXHIBIT 31.2 a2132097zex-31_2.txt EX-31.2 3881
12 EXHIBIT 32.1 a2132097zex-32_1.txt EX-32.1 1215
13 EXHIBIT 32.2 a2132097zex-32_2.txt EX-32.2 1383
  Complete submission text file 0001047469-04-010105.txt   933757
Mailing Address 12 OAK PARK DR BEDFORD MA 01730
Business Address 12 OAK PARK DR BEDFORD MA 01730 7816859700
NITROMED INC (Filer) CIK: 0000927829 (see all company filings)

EIN.: 223159793 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50439 | Film No.: 04701818
SIC: 2834 Pharmaceutical Preparations